Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06311617

Retinal Vascular Changes During Pregnancy

Understanding Retinal Vascular Changes During Pregnancy and the Impact on Maternal and Fetal Health

Status
Recruiting
Phase
Study type
Observational
Enrollment
90 (estimated)
Sponsor
Vanderbilt University Medical Center · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to better understand how the back part of the eye-called the retina and the choroid-changes during pregnancy. Specialized photos of the eye will be taken at three different timepoints: early in pregnancy (first or second trimester), late in pregnancy (third trimester), and after delivery. This imaging is non-invasive and does not require contact with the surface of the eye. The photos taken will allow assessment of specific parameters, like blood flow and the health of specialized cells that support vision. Understanding how the eyes change during pregnancy may help guide how retina specialists understanding of retinal disease during pregnancy and better inform pregnancy outcomes.

Detailed description

Pregnancy is a unique human condition marked by changes throughout the body, including changes in hormone levels, blood volume, blood pressure, and blood clot formation. These changes impact the eye as well, particularly the back part of the eye, called the retina and the choroid. Pre-existing conditions like diabetes and high blood pressure are known to affect the retina, but this impact may be increased by during pregnancy. In addition, new eye conditions may develop. The purpose of this study is to better understand how the retina and choroid changes during pregnancy.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTOptical coherence tomographyNon-mydriatic fundus photography and optical coherence tomography will be performed at 3 timepoints

Timeline

Start date
2024-02-01
Primary completion
2027-01-01
Completion
2027-01-01
First posted
2024-03-15
Last updated
2025-04-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06311617. Inclusion in this directory is not an endorsement.